CD19 CAR-T Cell Therapy at the LMU Munich from 2019 to 2021: Increasing Therapy Safety over the Years

被引：0
|
作者：
Bucklein, V [1 ,2 ,3 ]
Blumenberg, V [1 ,2 ,4 ]
Frolich, L. [1 ,4 ]
Ackermann, J. [1 ]
Schmidt, C. [1 ]
Hildebrand, F. [1 ,2 ]
Rejeski, K. [1 ,2 ,4 ]
Winkelmann, M. [5 ]
Schoberl, F. [6 ]
Kunz, W.
Von Baumgarten, L. [1 ,3 ,7 ]
Humpe, A. [8 ]
Von Bergwelt, M. [3 ,4 ]
Subklewe, M. [1 ,2 ,3 ,4 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany
[2] LMU Gene Ctr, Lab Translat Canc Immunol, Munich, Germany
[3] Bavarian Canc Res Ctr BZKF, Munich, Germany
[4] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Heidelberg, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
[6] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurol, Munich, Germany
[7] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurosurg, Munich, Germany
[8] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Transfus Med, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P388
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [31] Aggressive Lymphoma after CD19 CAR T-Cell Therapy
    Kobbe, Guido
    Bruggemann, Monika
    Baermann, Ben-Niklas
    Wiegand, Laura
    Trautmann, Heiko
    Yousefian, Schayan
    Libertini, Silvana
    Menssen, Hans D.
    Maier, Harald J.
    Ulrich, Peter
    Gao, Jingbo
    Bruch, Peter-Martin
    Liebers, Nora
    Radujkovic, Aleksandar
    Seifert, Marc
    Schniederjohann, Christina
    Paramasivam, Nagarajan
    Fitzgerald, Donnacha
    Seidel, Maximilian
    Esposito, Irene
    Germing, Ulrich
    Cadeddu, Ron-Patrick
    Nachtkamp, Kathrin
    Jaeger, Paul
    Ulrych, Thomas
    Fischer, Johannes C.
    Rox, Jutta M.
    Giesel, Frederik
    Koch, Raphael
    Antoch, Gerald
    Distler, Joerg H. W.
    Meuth, Sven G.
    Jacobsen, Malte
    Hubschmann, Daniel
    Lu, Junyan
    Iaccarino, Ingram
    Haas, Simon
    Damm, Frederik
    Dietrich, Sascha
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1217 - 1226
  • [32] Bone Marrow Fibrosis Is Associated with Non-Response to CD19 CAR-T Therapy
    Anil, Joshua
    Lytle, Andrew
    Alnemri, Ahab
    Lockhart, Brian
    Pillai, Vinodh
    BLOOD, 2022, 140 : 9194 - 9195
  • [33] Paving the road ahead for CD19 CAR T-cell therapy
    Nellan, Anandani
    Lee, Daniel W.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 516 - 520
  • [34] Secondary malignancy after CD19 CAR T-cell therapy
    Rudek, Loreen Sophie
    Alakus, Hakan
    ONKOLOGIE, 2025,
  • [35] Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
    Rejeski, Kai
    Burchert, Andreas
    Iacoboni, Gloria
    Sesques, Pierre
    Fransecky, Lars
    Buecklein, Veit
    Trenker, Corinna
    Hernani, Rafael
    Naumann, Ralph
    Schaefer, Jonas
    Blumenberg, Viktoria
    Schmidt, Christian
    Sohlbach, Kristina
    von Bergwelt-Baildon, Michael
    Bachy, Emmanuel
    Barba, Pere
    Subklewe, Marion
    BLOOD ADVANCES, 2022, 6 (16) : 4719 - 4725
  • [36] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Cao, Xing-Yu
    Li, Jing-Jing
    Lu, Pei-Hua
    Liu, Kai-Yan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 315 - 329
  • [37] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Xing-yu Cao
    Jing-jing Li
    Pei-hua Lu
    Kai-yan Liu
    International Journal of Hematology, 2022, 116 : 315 - 329
  • [38] Anti-CD19 CAR-T cell therapy for acquired hemophilia A
    Schultze-Florey, Christian R.
    Thol, Felicitas R.
    Aleksandrova, Krasimira
    Stoyanov, Kalin
    Gutierrez Jauregui, Rodrigo
    Arseniev, Lubomir
    Leise, Jana
    Kloess, Stephan
    Heidel, Florian H.
    Tiede, Andreas
    LEUKEMIA, 2025, : 980 - 982
  • [39] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    BLOOD, 2024, 144 : 2819 - 2819
  • [40] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
12345